Abstract
A common method for determining the patent status of medicines internationally is highly imprecise and complicates medicine access by obscuring the true medicine patent landscape for policymakers and procurement officers.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
